Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News PerkinElmer names new member of board of directors

PerkinElmer names new member of board of directors

1st August 2016

PerkinElmer has announced the appointment of Dr Frank Witney as the newest member of its board of directors.

Dr Witney is a veteran business leader within the life sciences industry, having most recently served as president and chief executive officer of Affymetrix, a specialist creator of microarray technology and cellular analysis that was recently acquired by Thermo Fisher Scientific.

Previously, he was president and chief executive of the market-leading ion and high-performance liquid chromatography company Dionex, and occupied the same role at the quantitative biology company Panomics.

Dr Witney also previously held the role of president of PerkinElmer's drug discovery tools division following the acquisition of Packard BioScience in 2001, meaning he has experience of serving within the company.

Robert Friel, chairman and chief executive officer at PerkinElmer, said: "I am delighted to welcome Frank to PerkinElmer's board, as he brings deep market knowledge and over 30 years of leadership experience across the life sciences, diagnostics and analytical instruments industry."

The firm has around 8,000 employees serving customers in more than 150 countries and achieved a constant currency-adjusted growth rate of seven percent in 2015.ADNFCR-8000103-ID-801822943-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.